Status:
COMPLETED
Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis
Lead Sponsor:
Mahidol University
Conditions:
Fungal Infection
Onychomycosis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The randomized control trial study aimed to evaluate effectiveness and safety of amphotericin B in 30% DMSO solution comparing with 30% DMSO solution in NDMs onychomycosis treatment.
Detailed Description
Introduction Onychomycosis caused by non-dermatophyte molds (NDMs) have become more common in clinical practice, particularly in tropical and subtropical area. With worldwide prevalence as high as 10-...
Eligibility Criteria
Inclusion
- Patients with non-dermatophyte onychomycosis.
- Patients aged more than 18 years.
- Patients has not been treated with any oral/ IV/ topical antifungal therapy within 36 weeks before enrolled.
Exclusion
- Patients had concomitant nail diseases.
- Immunocompromised host.
- Patients with dermatophyte onychomycosis.
Key Trial Info
Start Date :
January 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT03814343
Start Date
January 15 2019
End Date
November 30 2020
Last Update
September 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology Siriraj Hospital
Bangkoknoi, Bangkok, Thailand, 10700